2019

  • Lovland L, Jones R, Pichet Binette A, Villeneuve S, Marchant N, PREVENT-AD research group. (2019) Repetitive negative thinking predicts decline in memory and other cognitive functions. Alzheimer’s Society Conference. London, UK.

2018

  •  Pichet Binette A*, Vachon-Presseau E, Gonneaud J, Marchant N, Bellec P, Breitner JC, Villeneuve S, PREVENT-AD Research Group. (2018) Neuropsychiatric burden is related to increased amyloid but not tau deposition in late-middle-aged cognitively normal individuals with a family history of Alzheimer’s disease. NeuroQAM Annual Research Day. Montreal, CA. * Prize; Oral Presentation
  • Gonneaud J *, Vachon-Presseau E*, Baria A, Pichet Binette A, Benzinger T, Morris J, Bateman R, Breitner J, Poirier J, Villeneuve S for the PREVENT-AD research group. (2018) The preclinical phase of autosomal dominant Alzheimer’s disease is characterized by accelerated brain aging. Montreal Neurological Institute Brain Imaging Center Retreat. Montreal, CA. * Prize; Oral Presentation [PDF]
  • McSweeney M, Pichet Binette A, Meyer P-F, Gonneaud J, Bedetti C, Ozlen H, Daoust L-A, Labonté A, Poirier J, Rosa-Neto P, Breitner JC, Villeneuve S for the PREVENT-AD research group. (2018) Early increase in tau-PET signal is associated with Aβ burden, CSF p-tau levels and cognition in cognitively normal older adults. Brenda Milner Centennial Symposium. Montreal, CA.
  • Gonneaud J, Bedetti C, Pichet Binette A, Benzinger T, Morris R, Bateman R, Poirier J, Breitner JC, Villeneuve S, DIAN Study Group, Prevent-AD Research Group. (2018) Genetic and environmental factors are differentially related to Aβ burden in the presymptomatic phase of autosomal dominant and sporadic Alzheimer’s disease. Brenda Milner Centennial Symposium. Montreal, CA.
  • McSweeney M, Pichet Binette A, Meyer P-F, Gonneaud J, Bedetti C, Ozlen H, Daoust L-A, Labonté A, Poirier J, Rosa-Neto P, Breitner JC, Villeneuve S for the PREVENT-AD research group. (2018) Early increase in tau-PET signal is associated with Aβ burden, CSF p-tau levels and cognition in cognitively normal older adults. Douglas Research Day. Montreal, CA.
  • Pichet Binette A*, Vachon-Presseau E, Gonneaud J, Marchant N, Bellec P, Breitner JC, Villeneuve S, PREVENT-AD Research Group. (2018) Neuropsychiatric burden is related to increased amyloid but not tau deposition in late-middle-aged cognitively normal individuals with a family history of Alzheimer’s disease. Douglas Research Day. Montreal, CA.  * Prize
  • Gonneaud J, Bedetti C, Pichet Binette A, Benzinger T, Morris R, Bateman R, Poirier J, Breitner JC, Villeneuve S, DIAN Study Group, Prevent-AD Research Group. (2018) Genetic and environmental factors are differentially related to Aβ burden in the presymptomatic phase of autosomal dominant and sporadic Alzheimer’s disease. Douglas Research Day. Montreal, CA.  Oral Presentation
  • Pichet Binette A*, Vachon-Presseau E, Gonneaud J, Marchant N, Bellec P, Breitner JC, Villeneuve S, PREVENT-AD Research Group. (2018) Neuropsychiatric burden is related to increased amyloid but not tau deposition in late-middle-aged cognitively normal individuals with a family history of Alzheimer’s disease. Canadian Student Health Research Forum. Winnipeg, CA.  * Prize
  • McSweeney M, Pichet Binette A, Meyer P-F, Gonneaud J, Bedetti C, Ozlen H, Daoust L-A, Labonté A, Poirier J, Rosa-Neto P, Breitner JC, Villeneuve S for the PREVENT-AD research group. (2018) Early increase in tau-PET signal is associated with Aβ burden, CSF p-tau levels and cognition in cognitively normal late-middle-aged adults. 3rd Annual Neurosymposium. Montreal, CA.
  • McSweeney M, Pichet Binette A, Meyer P-F, Gonneaud J, Bedetti C, Ozlen H, Daoust L-A, Labonté A, Poirier J, Rosa-Neto P, Breitner JC, Villeneuve S for the PREVENT-AD research group. (2018) Early increase in tau-PET signal is associated with Aβ burden, CSF p-tau levels and cognition in cognitively normal late-middle-aged adults. 10th Annual Quebec Bio-imaging Network Research Day. Montreal, CA.
  • Pichet Binette A, Vachon-Presseau E, Gonneaud J, Marchant N, Bellec P, Breitner JC, Villeneuve S, PREVENT-AD Research Group. (2018) Neuropsychiatric burden is related to increased amyloid but not tau deposition in late-middle-aged cognitively normal individuals with a family history of Alzheimer’s disease. 10th Annual Quebec Bio-imaging Network Research Day. Montreal, CA.
  • Gonneaud J, Bedetti C, Pichet Binette A, Benzinger T, Morris R, Bateman R, Poirier J, Breitner JC, Villeneuve S, DIAN Study Group, Prevent-AD Research Group. (2018) Genetic and environmental factors are differentially related to Aβ burden in the presymptomatic phase of autosomal dominant and sporadic Alzheimer’s disease. 10th Annual Quebec Bio-imaging Network Research Day. Montreal, CA.

2016

  • Pichet Binette A, Vogel JW, Fonov V, Tremblay-Mercier J, Madjar C, Breitner J, Collins L, Poirier J, Villeneuve S, PREVENT-AD Research Group (2016) High CSF tau is related to reduced hippocampal volume and subjective cognitive decline in healthy elderly with amyloid pathology. Douglas Research Day.  Oral Presentation [PDF]
  • Vogel JW, Orban P, Pichet Binette A, La Joie R, Savard M, Tam A, Breitner J, Bellec P, Villeneuve S, PREVENT-AD. (2016) Regional gray matter volume and default mode network connectivity are associated with age relative to parental symptom onset in sporadic Alzheimer’s disease. Montreal, CA. [PDF]